Author: Yuan, Yuan; Cao, Duanfang; Zhang, Yanfang; Ma, Jun; Qi, Jianxun; Wang, Qihui; Lu, Guangwen; Wu, Ying; Yan, Jinghua; Shi, Yi; Zhang, Xinzheng; Gao, George F.
Title: Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains Document date: 2017_4_10
ID: 094lgjnn_15
Snippet: Implication for the design of broadly neutralizing antibodies. The S protein is the major antigen on the surface of the MERS-CoV or SARS-CoV virion. For MERS-CoV, most of the currently-available neutralizing antibodies were developed against the flexible RBD region [30] [31] [32] [33] [34] . For SARS-CoV, neutralizing antibodies against both S1 and S2 subunits have been developed 35, 36 . The accessibility of the RBD domain, due to its inherent f.....
Document: Implication for the design of broadly neutralizing antibodies. The S protein is the major antigen on the surface of the MERS-CoV or SARS-CoV virion. For MERS-CoV, most of the currently-available neutralizing antibodies were developed against the flexible RBD region [30] [31] [32] [33] [34] . For SARS-CoV, neutralizing antibodies against both S1 and S2 subunits have been developed 35, 36 . The accessibility of the RBD domain, due to its inherent flexibility, as shown in this study provides an explanation for the high efficiency of RBD-directed neutralizing antibodies. Since the RBD is located between the NTD domains, a strategy to develop neutralizing antibodies, which target the NTD and interfering with receptor binding through steric hindrance should be feasible in the future.
Search related documents:
Co phrase search for related documents- broadly neutralize and neutralizing antibody: 1, 2
- broadly neutralize and RBD domain: 1
- broadly neutralize and SARS cov: 1, 2, 3, 4
- broadly neutralize antibody and neutralize antibody: 1
- broadly neutralize antibody and SARS cov: 1
- flexible RBD region and major antigen: 1
- flexible RBD region and RBD domain: 1, 2
- flexible RBD region and RBD region: 1, 2
- flexible RBD region and SARS cov: 1, 2
- high efficiency and major antigen: 1
- high efficiency and neutralizing antibody: 1, 2, 3, 4
- high efficiency and RBD domain: 1, 2, 3, 4
- high efficiency and RBD region: 1
- high efficiency and receptor bind: 1
- high efficiency and SARS cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- high efficiency and steric hindrance: 1
- high efficiency and study show: 1
- inherent flexibility and NTD domain: 1
- inherent flexibility and RBD domain: 1
Co phrase search for related documents, hyperlinks ordered by date